Data protection Impressum

Financing

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (February 2026)

25 February 2026

The Fonds pour l’Innovation et le Futur de Genève (FIF) has awarded Seed funding to four early-stage projects in Geneva, reinforcing the canton’s digital and impact-driven innovation ecosystem.

FIF supports four start-ups to reinforce Geneva’s impact-driven innovation ecosystem

24 February 2026

Three Western Switzerland cleantech and medtech start-ups have received FIT support to scale geothermal panels, rapid bacteria detection and carbon capture filters.

FIT backs Enerdrape, Bioneris and Divea with growth and seed loans

24 February 2026

The canton of Vaud seeks CHF 207.6 million to deploy a unified digital patient record across CHUV and regional hospitals.

The canton of Vaud commits over CHF 200 million to next-generation digital patient record

18 February 2026

Lausanne-based CompPair has raised new funding to scale its HealTech self-healing composites and strengthen industrial deployment.

CompPair secures new funding to accelerate market deployment of healable composites

18 February 2026

Vaud-based start-up Algorized raises USD 13 million to scale human-aware perception for industrial robotics.

Algorized raises USD 13 million to advance Physical AI for industrial robotics

16 February 2026

Lausanne-based Scholé AI has raised USD 3 million to expand its AI-driven learning platform, supporting enterprise adoption of practical, role-specific AI skills.

Scholé AI raises USD 3 million to scale its AI-native workforce learning platform

10 February 2026

EPFL Innovation Park-based AlphaLum has raised CHF 3.4 million to accelerate the industrialization of its optics and sensing platform for next-generation smart glasses and spatial computing.

AlphaLum raises CHF 3.4 million to scale optics and sensing technologies for smart glasses

10 February 2026

HemostOD has been awarded a CHF 2 million Innosuisse grant to support the preclinical development of its donor-free, off-the-shelf human blood platelets for transfusion.

HemostOD secures CHF 2 million to advance donor-free platelet development

9 February 2026

Swiss start-ups raised CHF 2.9 billion in 2025, marking a strong recovery in venture capital investment led by ICT and biotech.

Swiss start-ups attract CHF 2.9 billion in 2025 as venture capital rebounds

3 February 2026

1 2 3 4 5 6 … 40